Physician profile
James E Henry
NPI 1366550691
$3,192.86
in general payments reported to CMS, 2019-2025
11 companies · $664 in 2025
The $664 reported for 2025 was less than what a typical Adult Reconstructive Orthopaedic Surgery provider received nationally (typical 2025 total: $1,425).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $399 · 2020: $392 · 2021: $633 · 2022: $416 · 2023: $297 · 2024: $392 · 2025: $664.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,152 · Education: $200.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,152.37 |
| Education | $199.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $1,451.10 | 2019-2025 | Mako, T2, Gamma |
| Depuy Synthes Sales INC. | $506.91 | 2019-2025 | Healix Knotless Peek, Gryphon Orthocord, Vapr |
| Nevro Corp. | $320.21 | 2019-2020 | |
| Medical Device Business Services, INC. | $199.99 | 2025 | Actis |
| Avanos Medical | $160.12 | 2020 | |
| Spr Therapeutics, INC | $150.00 | 2022 | |
| Boston Scientific Corporation | $133.86 | 2021 | |
| Relievant Medsystems, INC. | $118.55 | 2021 | |
| E.R. Squibb & Sons, L.L.C. | $118.37 | 2025 | |
| Horizon Therapeutics Plc | $18.61 | 2021 | |
| Cumberland Pharmaceuticals, INC. | $15.14 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Henry listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.